Skip to main content
. 2006 Jan 10;94(2):268–274. doi: 10.1038/sj.bjc.6602929

Table 2. Gain of somatic mutations of the entire mitochodrial DNA genome in renal carcinoma tissues.

Case Tumour type Grade Nucleotide position Heteroplasmya in tumour (%) Gene Amino acid Notes
1 Conv. RCb 2/3 C338T <25 D-loop   c
1     A1578G <25 12S rRNA   d
1     G12007A <25 ND4 syn c
2 Conv. RC 3 G4584A <25 ND2 A39T d
3 Conv. RC 2 G94A >75 D-loop   c
3     A7423G <25 COI E507G d
4 Conv. RC 3 T204C 25–75 D-loop   c
4     A3243G >75 tRNA LEU(UUR)   MELAS
4     G1169A >75 12S rRNA   d
4     C12510A >75 ND5 D58E d
5 Papillary RC 1 T2222C 25–75 16S rRNA   d
6 Papillary RC 2 C1566T <25 12S rRNA   d
6     T10579C <25 ND4L M37T d
7 Sarkomatoid RC 4 C16174T 25–75 D-loop   c
a

Estimated by denaturating HPLC analysis.

b

Conv.=conventional; RC=renal carcinoma; syn=synonymous.

cPreviously reported polymorphism (MITOMAP database).

dNovel mutation.